Furthermore, in experimental models of CRC, chemotherapy-stimulated CAFs increase the secretion of specific cytokines, such as IL-17A, which promotes chemoresistance through the NF-κB pathway and increases tumor invasion and growth in vivo. The gene discussed is NFKB1; the disease is neoplasm.